Nasdaq, Nanogen, Uniscience, Partek, Elan Pharmaceuticals, Ariadne Genomics, Biolytix, Affymetrix, Georgia Institute of Technology, BioForce Nanosciences | GenomeWeb
Nasdaq Notifies Nanogen of Delisting Status on Minimum Bid Price
The Nasdaq Stock Market has notified Nanogen that it may delist the company’s stock from the market due to failure to maintain a minimum bid price for 30 days, the company said last week.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.